Oct 25, 2018
AMPEL's System For Drug Repositioning Confirmed By Success Of Phase 2 Trial Of Stelara In Lupus
Oct 23, 2018
New Phase 2 Data Show Stelara® (Ustekinumab) Sustained Improvement In Disease Activity In Adults With Systemic Lupus Erythematosus Through One Year
Oct 21, 2018
DxTerity Announces Presentations from Lupus and Multiple Sclerosis Studies at the 2018 ACR/ARHP Annual Meeting
Oct 17, 2018
OM1 Lupus Registry Reaches More Than 25,000 Patients Prospectively Followed With Deep Clinical And Lab Data
Oct 09, 2018
Global Systemic Lupus Erythematosus Market and Competitive Landscape 2014-2018 & 2023
Oct 08, 2018
Global Orphan and Rare Dermatology Drugs Market 2018-2024: Focus on Systemic Sclerosis, Alopecia, Epidermolysis Bullosa, Pemphigus Vulgaris, Vitiligo and Cutaneous Lupus Erythematosus
Oct 05, 2018
Xencor Announces Topline Results from Phase 2 Study of XmAb®5871 in Systemic Lupus Erythematosus and Selection of Late-Breaking Abstract for Presentation at the 2018 ACR Annual Meeting
Sep 12, 2018
SLE Market Size Worth $3.08 Billion by 2025 | CAGR 7.0%: Grand View Research, Inc.
Jul 25, 2018
Analysis of Over 1,000 Systemic Lupus Erythematosus Patients Reveals Real World Patient Populations are Not Representative of Clinical Trial Samples
Jun 07, 2018
DxTerity Announces Preliminary Results from the LIFT Study will be Presented at the 2018 Annual European Congress of Rheumatology
May 09, 2018
Provention Bio Announces Agreements with MacroGenics for Two Clinical-Stage Assets for the Treatment of Autoimmune Disorders
May 08, 2018
Nektar Therapeutics Announces Initiation of a Phase 1b Clinical Study of NKTR-358, a First-in-Class Regulatory T Cell Stimulator, in Patients with Systemic Lupus Erythematosus
Mar 06, 2018
One in 250 Females Likely to Develop Lupus During Child-Bearing Years
Dec 05, 2017
AMPEL BioSolutions, Horizon Pharma plc, and Lupus Research Alliance Partner on Unique Clinical Trial for Patients with Lupus
Nov 07, 2017
GSK Presents New Data at ACR for BENLYSTA (belimumab) for Subcutaneous Use (SC), Showing Reduced Need to Increase Corticosteroid Dose
Nov 06, 2017
STELARA® (ustekinumab) Shows Positive Results In Treatment Of Systemic Lupus Erythematosus In Phase 2 Trial
Nov 06, 2017
New GSK Multi-country Survey Reveals Need for Improved Awareness Around Long-term Impact and Appropriate use of Corticosteroids in SLE Management
Nov 05, 2017
Study Leads to a New Approach for Evaluating the Effectiveness of Experimental Therapies in Clinical Trials
Nov 01, 2017
EMD Serono And Lupus Foundation Of America Launch Initiative To Improve Future Of Lupus Care
Oct 31, 2017
Lupus Research Alliance LuCIN Clinical Trials Network Launches Inaugural Studies